What the studies show
Reports of anxiety reduction in generalised anxiety disorder, some comparing against benzodiazepines. Small, from the originating institutes, not independently replicated.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1Searches of PubMed and trial registries for Selank human trials outside Russia.LYO literature search, September 2026No independently replicated randomised trials identified.
In context
Selank is a synthetic analogue of tuftsin, an immune-signalling peptide, developed in Russia alongside Semax and registered there as an anxiolytic. Small Russian studies report anxiety reduction comparable to benzodiazepines without sedation; none has been replicated internationally or published to standards that allow the claim to be checked. It is not approved in the EU, US or UK.
Selank is not approved (outside russia). Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Selank proven to help with anxiety?
What studies are behind the grade?
Is Selank approved for this?
Other outcomes for Selank
- DCognitive effectsNone controlled internationally
- DSafety in humansadverseNo systematic international data
Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →